{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T04:05:48Z","timestamp":1790654748194,"version":"4.1.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2017,10,10]],"date-time":"2017-10-10T00:00:00Z","timestamp":1507593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Psychiatry"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1038\/mp.2017.156","type":"journal-article","created":{"date-parts":[[2017,10,10]],"date-time":"2017-10-10T04:01:24Z","timestamp":1507608084000},"page":"2156-2166","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":219,"title":["Dose-dependent expression of claudin-5 is a modifying factor in schizophrenia"],"prefix":"10.1038","volume":"23","author":[{"given":"C","family":"Greene","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Kealy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M M","family":"Humphries","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Hudson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L M","family":"Cassidy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Martiniano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V","family":"Shashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S R","family":"Hooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G A","family":"Grant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P F","family":"Kenna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Norris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C K","family":"Callaghan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M dN","family":"Islam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S M","family":"O\u2019Mara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z","family":"Najda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S G","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J S","family":"Pachter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N M","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Humphries","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K C","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,10,10]]},"reference":[{"key":"149_CR1","unstructured":"World Health Organization, World Health Organization, Apr. 2016, retrieved from: www.who.int\/mediacentre\/factsheets\/fs397\/en\/. Schizophrenia."},{"key":"149_CR2","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/S0896-6273(00)00111-2","volume":"28","author":"DA Lewis","year":"2000","unstructured":"Lewis DA, Lieberman JA. Catching up on schizophrenia: natural history and neurobiology. Neuron 2000; 28: 325\u2013334.","journal-title":"Neuron"},{"key":"149_CR3","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1001\/archpsyc.62.3.247","volume":"62","author":"BA Palmer","year":"2005","unstructured":"Palmer BA, Pankratz VS, Bostwick JM. The lifetime risk of suicide in schizophrenia: a re-examination. Arch Gen Psychiatry 2005; 62: 247\u2013253.","journal-title":"Arch Gen Psychiatry"},{"key":"149_CR4","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1093\/schbul\/22.2.327","volume":"22","author":"TH McGlashan","year":"1996","unstructured":"McGlashan TH. Early detection and intervention in schizophrenia research. Schizophr Bull 1996; 22: 327\u2013345.","journal-title":"Schizophr Bull"},{"key":"149_CR5","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/S0920-9964(99)00154-1","volume":"43","author":"L Voruganti","year":"2000","unstructured":"Voruganti L, Cortese L, Oyewumi L, Cernovsky Z, Awad A. Comparative evaluation of conventional and novel antipsychotic drugs with reference to their subjective tolerability, side-effect profile and impact on quality of life. Schizophr Res 2000; 43: 135\u2013145.","journal-title":"Schizophr Res"},{"key":"149_CR6","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S0140-6736(08)61764-X","volume":"373","author":"S Leucht","year":"2009","unstructured":"Leucht S, Corves C, Arbter D, Engel RR, Li C, Davis JM. Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis. Lancet 2009; 373: 31\u201341.","journal-title":"Lancet"},{"key":"149_CR7","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/S0006-3223(99)00281-4","volume":"47","author":"AE Pulver","year":"2000","unstructured":"Pulver AE. Search for schizophrenia vulnerability genes. Biol Psychiatry 2000; 47: 221\u2013230.","journal-title":"Biol Psychiatry"},{"key":"149_CR8","doi-asserted-by":"publisher","first-page":"3717","DOI":"10.1073\/pnas.042700699","volume":"99","author":"H Liu","year":"2002","unstructured":"Liu H, Heath SC, Sobin C, Roos JL, Galke BL, Blundell ML et al. Genetic variation at the 22q11 PRODH2\/DGCR6 locus presents an unusual pattern and increases susceptibility to schizophrenia. Proc Natl Acad Sci USA 2002; 99: 3717\u20133722.","journal-title":"Proc Natl Acad Sci USA"},{"key":"149_CR9","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/mp.2013.156","volume":"19","author":"E Rees","year":"2014","unstructured":"Rees E, Kirov G, Sanders A, Walters JT, Chambert KD, Shi J et al. Evidence that duplications of 22q11.2 protect against schizophrenia. Mol Psychiatry 2014; 19: 37\u201340.","journal-title":"Mol Psychiatry"},{"key":"149_CR10","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/S0140-6736(02)07604-3","volume":"359","author":"KC Murphy","year":"2002","unstructured":"Murphy KC. Schizophrenia and velo-cardio-facial syndrome. Lancet 2002; 359: 426\u2013430.","journal-title":"Lancet"},{"key":"149_CR11","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1093\/schbul\/sbr095","volume":"37","author":"NM Williams","year":"2011","unstructured":"Williams NM. Molecular mechanisms in 22q11 deletion syndrome. Schizophr Bull 2011; 37: 882\u2013889.","journal-title":"Schizophr Bull"},{"key":"149_CR12","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1002\/ajmg.a.30133","volume":"129A","author":"A Kao","year":"2004","unstructured":"Kao A, Mariani J, McDonald-McGinn DM, Maisenbacher MK, Brooks-Kayal AR, Zackai EH et al. Increased prevalence of unprovoked seizures in patients with a 22q11.2 deletion. Am J Med Genet A 2004; 129A: 29\u201334.","journal-title":"Am J Med Genet A"},{"key":"149_CR13","first-page":"1","volume":"9","author":"SX Tang","year":"2013","unstructured":"Tang SX, Yi JJ, Calkins ME, Whinna DA, Kohler CG, Souders MC et al. Psychiatric disorders in 22q11.2 deletion syndrome are prevalent but undertreated. Psychol Med 2013; 9: 1\u201311.","journal-title":"Psychol Med"},{"key":"149_CR14","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.nbd.2009.07.030","volume":"37","author":"NJ Abbott","year":"2010","unstructured":"Abbott NJ, Patabendige AA, Dolman DE, Yusof SR, Begley DJ. Structure and function of the blood-brain barrier. Neurobiol Dis 2010; 37: 13\u201325.","journal-title":"Neurobiol Dis"},{"key":"149_CR15","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/nrn1824","volume":"7","author":"NJ Abbott","year":"2006","unstructured":"Abbott NJ, Ronnback L, Hansson E. Astrocyte-endothelial interactions at the blood-brain barrier. Nat Rev Neurosci 2006; 7: 41\u201353.","journal-title":"Nat Rev Neurosci"},{"key":"149_CR16","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1602\/neurorx.2.1.3","volume":"2","author":"WM Pardridge","year":"2005","unstructured":"Pardridge WM. The blood-brain barrier: bottleneck in brain drug development. NeuroRx 2005; 2: 3\u201314.","journal-title":"NeuroRx"},{"key":"149_CR17","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1124\/pr.57.2.4","volume":"57","author":"BT Hawkins","year":"2005","unstructured":"Hawkins BT, Davis TP. The blood-brain barrier\/neurovascular unit in health and disease. Pharmacol Rev 2005; 57: 173\u2013185.","journal-title":"Pharmacol Rev"},{"key":"149_CR18","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1038\/nm.3407","volume":"19","author":"B Obermeier","year":"2013","unstructured":"Obermeier B, Daneman R, Ransohoff RM. Development, maintenance and disruption of the blood-brain barrier. Nat Med 2013; 19: 1584\u20131596.","journal-title":"Nat Med"},{"key":"149_CR19","doi-asserted-by":"publisher","first-page":"e11089","DOI":"10.1371\/journal.pone.0011089","volume":"5","author":"T Falcone","year":"2010","unstructured":"Falcone T, Fazio V, Lee C, Simon B, Franco K, Marchi N et al. Serum S100B: a potential biomarker for suicidality in adolescents? PLoS ONE 2010; 5: e11089.","journal-title":"PLoS ONE"},{"key":"149_CR20","doi-asserted-by":"publisher","first-page":"65","DOI":"10.3371\/CSRP.FACA.030813","volume":"9","author":"T Falcone","year":"2015","unstructured":"Falcone T, Carlton E, Lee C, Janigro M, Fazio V, Forcen FE et al. Does systemic inflammation play a role in pediatric psychosis? Clin Schizophr Relat Psychoses 2015; 9: 65\u201378B.","journal-title":"Clin Schizophr Relat Psychoses"},{"key":"149_CR21","doi-asserted-by":"publisher","first-page":"e1500472","DOI":"10.1126\/sciadv.1500472","volume":"1","author":"J Keaney","year":"2015","unstructured":"Keaney J, Walsh DM, O'Malley T, Hudson N, Crosbie DE, Loftus T et al. Autoregulated paracellular clearance of amyloid-\u03b2 across the blood-brain barrier. Sci Adv 2015; 1: e1500472.","journal-title":"Sci Adv"},{"key":"149_CR22","doi-asserted-by":"publisher","first-page":"4067","DOI":"10.1111\/febs.13412","volume":"282","author":"J Keaney","year":"2015","unstructured":"Keaney J, Campbell M. The dynamic blood-brain barrier. FEBS J 2015; 282: 4067\u20134079.","journal-title":"FEBS J"},{"key":"149_CR23","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1016\/j.celrep.2014.09.040","volume":"9","author":"J Lui","year":"2014","unstructured":"Lui J, Castelli LM, Pizzinga M, Simpson CE, Hoyle NP, Bailey KL et al. Granules harboring translationally active mRNAs provide a platform for P-body formation following stress. Cell Rep 2014; 9: 944\u2013954.","journal-title":"Cell Rep"},{"key":"149_CR24","unstructured":"Nagy A, Gertsenstein M, Vintersten K, Behringer R. Manipulating the Mouse Embryo: A Laboratory Manual. Cold Spring Harbor, Laboratory Press, 2003."},{"key":"149_CR25","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1038\/ng2045","volume":"39","author":"RA Dickins","year":"2007","unstructured":"Dickins RA, McJunkin K, Hernando E, Premsrirut PK, Krizhanovsky V, Burgess DJ et al. Tissue-specific and reversible RNA interference in transgenic mice. Nat Genet 2007; 39: 914\u2013921.","journal-title":"Nat Genet"},{"key":"149_CR26","doi-asserted-by":"publisher","first-page":"e54","DOI":"10.1093\/nar\/gkm122","volume":"35","author":"J Seibler","year":"2007","unstructured":"Seibler J, Kleinridders A, Kuter-Luks B, Niehaves S, Bruning JC, Schwenk F. Reversible gene knockdown in mice using a tight, inducible shRNA expression system. Nucleic Acids Res 2007; 35: e54.","journal-title":"Nucleic Acids Res"},{"key":"149_CR27","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.cell.2011.03.012","volume":"145","author":"PK Premsrirut","year":"2011","unstructured":"Premsrirut PK, Dow LE, Kim SY, Camiolo M, Malone CD, Miethingi C et al. A rapid and scalable system for studying gene function in mice using conditional RNA interference. Cell 2011; 145: 145\u2013158.","journal-title":"Cell"},{"key":"149_CR28","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.eurpsy.2004.06.007","volume":"19","author":"ZY Sun","year":"2004","unstructured":"Sun ZY, Wei J, Xie L, Shen Y, Liu SZ, Ju GZ et al. The CLDN5 locus may be involved in the vulnerability to schizophrenia. Eur Psychiatry 2004; 19: 354\u2013357.","journal-title":"Eur Psychiatry"},{"key":"149_CR29","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.schres.2004.11.003","volume":"75","author":"L Ye","year":"2005","unstructured":"Ye L, Sun Z, Xie L, Liu S, Ju G, Shi J et al. Further study of a genetic association between the CLDN5 locus and schizophrenia. Schizophr Res 2005; 75: 139\u2013141.","journal-title":"Schizophr Res"},{"key":"149_CR30","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.psychres.2009.11.019","volume":"178","author":"N Wu","year":"2010","unstructured":"Wu N, Zhang X, Jin S, Liu S, Ju G, Wang Z et al. A weak association of the CLDN5 locus with schizophrenia in Chinese case-control samples. Psychiatry Res 2010; 178: 223.","journal-title":"Psychiatry Res"},{"key":"149_CR31","first-page":"79","volume":"43","author":"E Omidinia","year":"2014","unstructured":"Omidinia E, Mashayekhi Mazar F, Shahamati P, Kianmehr A, Shahbaz Mohammadi H. Polymorphism of the CLDN5 gene and schizophrenia in an Iranian population. Iran J Public Health 2014; 43: 79\u201383.","journal-title":"Iran J Public Health"},{"key":"149_CR32","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1002\/emmm.201100126","volume":"3","author":"M Campbell","year":"2011","unstructured":"Campbell M, Humphries MM, Kiang AS, Nguyen AT, Gobbo OL, Tam LC et al. Systemic low-molecular weight drug delivery to pre-selected neuronal regions. EMBO Mol Med 2011; 3: 235\u2013245.","journal-title":"EMBO Mol Med"},{"key":"149_CR33","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1083\/jcb.200302070","volume":"161","author":"T Nitta","year":"2003","unstructured":"Nitta T, Hata M, Gotoh S, Seo Y, Sasaki H, Hashimoto N et al. Size-selective loosening of the blood-brain barrier in claudin-5-deficient mice. J Cell Biol 2003; 161: 653\u2013660.","journal-title":"J Cell Biol"},{"key":"149_CR34","doi-asserted-by":"publisher","first-page":"e3964","DOI":"10.1371\/journal.pone.0003964","volume":"3","author":"LW Harris","year":"2008","unstructured":"Harris LW, Wayland M, Lan M, Ryan M, Giger T, Lockstone H et al. The cerebral microvasculature in schizophrenia: a laser capture microdissection study. PLoS ONE 2008; 3: e3964.","journal-title":"PLoS ONE"},{"key":"149_CR35","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1056\/NEJMoa051688","volume":"353","author":"JA Lieberman","year":"2005","unstructured":"Lieberman JA, Stroup TS, McEvoy JP, Swartz MS, Rosenheck RA, Perkins DO et al. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med 2005; 353: 1209\u20131223.","journal-title":"N Engl J Med"},{"key":"149_CR36","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.semcdb.2014.11.004","volume":"38","author":"RF Haseloff","year":"2015","unstructured":"Haseloff RF, Dithmer S, Winkler L, Wolburg H, Blasig IE. Transmembrane proteins of the tight junctions at the blood-brain barrier: structural and functional aspects. Semin Cell Dev Biol 2015; 38: 16\u201325.","journal-title":"Semin Cell Dev Biol"},{"key":"149_CR37","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1111\/j.1582-4934.2011.01380.x","volume":"16","author":"I Mandel","year":"2012","unstructured":"Mandel I, Paperna T, Glass-Marmor L, Volkowich A, Badarny S, Schwartz I et al. Tight junction proteins expression and modulation in immune cells and multiple sclerosis. J Cell Mol Med 2012 Apr; 16: 765\u2013775.","journal-title":"J Cell Mol Med"},{"key":"149_CR38","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3389\/fncel.2014.00021","volume":"8","author":"S Garbuzova-Davis","year":"2014","unstructured":"Garbuzova-Davis S, Sanberg PR. Blood-CNS barrier impairment in ALS patients versus an animal model. Front Cell Neurosci 2014; 8: 21.","journal-title":"Front Cell Neurosci"},{"key":"149_CR39","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1093\/jnen\/nlw036","volume":"75","author":"CP Doherty","year":"2016","unstructured":"Doherty CP, O'Keefe E, Wallace E, Loftus T, Keaney J, Kealy J et al. Blood-brain barrier dysfunction as a hallmark pathology in chronic traumatic encephalopathy. J Neuropathol Exp Neurol 2016; 75: 656\u2013662.","journal-title":"J Neuropathol Exp Neurol"},{"key":"149_CR40","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1073\/pnas.1309324111","volume":"111","author":"A McLysaght","year":"2014","unstructured":"McLysaght A, Makino T, Grayton HM, Tropeano M, Mitchell KJ, Vassos E et al. Ohnologs are overrepresented in pathogenic copy number mutations. Proc Natl Acad Sci USA 2014; 111: 361\u2013366.","journal-title":"Proc Natl Acad Sci USA"},{"key":"149_CR41","doi-asserted-by":"publisher","first-page":"9270","DOI":"10.1073\/pnas.0914697107","volume":"107","author":"M Takashi","year":"2010","unstructured":"Takashi M, McLysaght A. Ohnologs in the human genome are dosage balanced and frequently associated with disease. Proc Natl Acad Sci USA 2010; 107: 9270\u20139274.","journal-title":"Proc Natl Acad Sci USA"},{"key":"149_CR42","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/nature16549","volume":"530","author":"A Sekar","year":"2016","unstructured":"Sekar A, Bialas AR, de Rivera H, Davis A, Hammond TR, Kamitaki N et al. Schizophrenia risk from complex variation of complement component 4. Nature 2016; 530: 177\u2013183.","journal-title":"Nature"}],"container-title":["Molecular Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/mp.2017.156","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/mp.2017.156.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/mp.2017.156","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/www.nature.com\/articles\/mp.2017.156.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T14:13:34Z","timestamp":1684419214000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/mp.2017.156"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,10]]},"references-count":42,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["149"],"URL":"https:\/\/doi.org\/10.1038\/mp.2017.156","relation":{},"ISSN":["1359-4184","1476-5578"],"issn-type":[{"value":"1359-4184","type":"print"},{"value":"1476-5578","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,10]]},"assertion":[{"value":"31 March 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2017","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2017","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2017","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}